Copyright & Content Use | Lichen Sclerosus Journal

Legal

Copyright & Content Use

Last updated: April 2026  ·  lichensclerosusjournal.com

What is protected

The following are protected by copyright and, where applicable, by intellectual property law:

Permitted and restricted uses

✓ Permitted

  • Reading and personal use
  • Sharing links to articles
  • Quoting up to 100 words with attribution and a link to the original
  • Printing individual articles for personal reference
  • Referencing the framework in academic or clinical contexts with attribution

✗ Not permitted

  • Reproducing full articles or substantial portions
  • Publishing Site content on other websites or platforms
  • Using the biological framework in commercial products without a license
  • Scraping or harvesting content for AI training
  • Translating and republishing without permission
  • Presenting Site content as your own work

Patient communities and sharing

Sharing article links in patient communities, Facebook groups, Reddit threads, and similar spaces is encouraged and welcome. Copying and pasting full article text into posts or comments — even with attribution — is not permitted, as it reproduces the content without authorization and removes it from its medical disclaimer context.

Healthcare providers and clinicians

Clinicians who wish to share framework materials with patients may use brief excerpts with attribution. For permission to reproduce framework diagrams, phase model summaries, or article content in clinical materials, contact support@lichensclerosusjournal.com.

AI training and automated use

Use of any content from this Site for the purpose of training, fine-tuning, or evaluating artificial intelligence models — including large language models — is expressly prohibited without a written licensing agreement. This applies to all content formats including text, structural frameworks, and editorial organization.

Licensing and permissions

For reproduction rights, commercial licensing, translation rights, or any use not described above, contact:

Email: support@lichensclerosusjournal.com

We respond to licensing inquiries within 5 business days.